13 of 20
BACKNEXT
13. Bristol-Myers Squibb
Fortune 500 rank: 114
2009 profit: $10.6 billion
Bristol-Myers Squibb is a pure biotechnology-pharmaceutical after two years of transformation. As it moves away from selling health-care products, the company is cutting $2.5 billion in costs by 2012.

It's also spinning off old businesses, like Mead Johnson Nutritionals. Bristol-Myers earned $7.2 billion from the Mead IPO in 2009, which helped more than double profits.

NEXT: 14. Chevron

Email | Print | Share
 
google my aol my msn my yahoo! netvibes
Paste this link into your favorite RSS desktop reader
See all CNNMoney.com RSS FEEDS (close)
Last updated April 28 2010: 12:41 PM ET
Top 50 Wal-Mart knocks Exxon Mobil out of the No. 1 slot to rule the Fortune 500 again. Which other companies made the top 50 this year? More
They're hiring!These Fortune 100 employers have at least 200 openings each, totaling more than 60,000 jobs. What are they looking for in a new hire? More
The biggest losers Companies from Fannie Mae to RiteAid, and Citigroup to Sprint lost billions of dollars last year. Who lost the most? More

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.